CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-21 | Carter Jason S Chief Legal Officer | Sale | −3,864 | $27.82 | $107K | 49,136 |
| 2025-11-13 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | +10,000 | $3.94 | $39K | 57,839 |
| 2025-11-13 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise · Stock Option (right to buy) | −10,000 | 48,589 | ||
| 2025-11-11 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | −15,000 | $29.06 | $436K | 47,839 |
| 2025-06-24 | ENRIGHT PATRICK G Director | Purchase | +13,536 | $22.35 | $303K | 1,797,619 |
| 2025-06-24 | ENRIGHT PATRICK G Director | Purchase | +27,071 | $22.35 | $605K | 3,596,593 |
| 2025-06-23 | ENRIGHT PATRICK G Director | Purchase | +69,798 | $20.87 | $1.5M | 1,784,083 |
| 2025-06-23 | ENRIGHT PATRICK G Director | Purchase | +139,595 | $20.87 | $2.9M | 3,569,522 |
| 2025-05-14 | Katabi Maha Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | Oliger Christy J. Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | MORRISSEY MICHAEL Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | Hall Kimball Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-05-14 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2025-02-26 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −7,975 | $27.55 | $220K | 205,765 |
| 2025-02-26 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,100 | $28.32 | $31K | 204,665 |
| 2025-02-21 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −10,613 | $27.89 | $296K | 213,740 |
| 2025-02-18 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Grant or award | +10,740 | 61,946 |
Page 5 of 17 · 321 trades